Alnylam Pharmaceuticals
ALNY
#578
Rank
ยฃ25.89 B
Marketcap
ยฃ200.11
Share price
-1.75%
Change (1 day)
66.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company